Cs-131 Prostate Brachytherapy and Treatment Plan Parameters

Cancer types prostate


Sutlief S and Wallner K

Medical Physics
June 1, 2007
Drs. Sutlief and Wallner from Seattle report on a dosimetric study of Cesium-131 implants. They conclude that Cesium implants result in fewer “hotspots” than the other isotopes, are resistant to small errors in source placement, and require fewer seeds for large prostates.

Related posts

Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131

Authors: Glaser SM, Chen KS, Benoit RM, Smith RP, Beriwal S.

Long-term biochemical outcomes using cesium-131 in prostate brachytherapy.

Authors: Moran BJ, Rice SR, Chhabra AM, Amin N, Braccioforte M, Agarwal M.

Dosimetric Comparison of Cesium-131 and Palladium-103 for Permanent Prostate Brachytherapy

Authors: J.S. Musmacher, R.T. Byrnes, M. Ghaly, K. Satchwill, L. Rumpf

Scroll to top